Toward improved effectiveness of bladder cancer immunotherapy

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

(2015) Suzanne L. Topalian et al.   CANCER CELL

Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin

(2015) Alvaro Morales et al.   JOURNAL OF UROLOGY

The development of immunotherapy in urothelial bladder cancer

(2015) Tom Powles   Nature Reviews Clinical Oncology

Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

(2015) Ashish M. Kamat et al.   Nature Reviews Urology

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction

(2015) Ravikumar Muthuswamy et al.   Journal for ImmunoTherapy of Cancer

Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette-Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity

(2014) M. R. Newton et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

(2014) Thomas Powles et al.   NATURE

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies

(2013) Shimiao Zhu et al.   BMC CANCER

TLR agonists: our best frenemy in cancer immunotherapy

(2013) Sabina Kaczanowska et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

Rational combinations of immunotherapeutics that target discrete pathways

(2013) Stefani Spranger et al.   Journal for ImmunoTherapy of Cancer

Immunotherapy of cancer in 2012

(2012) John M. Kirkwood et al.   CA-A CANCER JOURNAL FOR CLINICIANS

NF- B Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

(2012) R. Muthuswamy et al.   CANCER RESEARCH

Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells

(2009) P. B. Watchmaker et al.   JOURNAL OF IMMUNOLOGY

Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation

(2008) R. Muthuswamy et al.   CANCER RESEARCH

The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Gúerin immunotherapy

(2008) Ofer N. Gofrit et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

(2007) Harry W. Herr et al.   JOURNAL OF UROLOGY